Literature DB >> 1999020

Is iron sufficiency a risk factor in ischemic heart disease?

J M McCord.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1999020     DOI： 10.1161/01.cir.83.3.1112

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

1.  Excessive body iron stores are not associated with risk of coronary heart disease in women.

Authors:  Qi Sun; Jing Ma; Nader Rifai; Oscar H Franco; Kathryn M Rexrode; Frank B Hu
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

Review 2.  Iron deficiency and cardiovascular disease: an updated review of the evidence.

Authors:  Emanuela Lapice; Maria Masulli; Olga Vaccaro
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

3.  Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys.

Authors:  R Baliga; N Ueda; S V Shah
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

4.  Reply to Tomoyuki Kawada, MD: "Red meat consumption and biological markers of metabolic disorders".

Authors:  D A Hobbs-Grimmer; D I Givens; J A Lovegrove
Journal:  Eur J Nutr       Date:  2021-06-21       Impact factor: 5.614

5.  Adaptations to iron deficiency: cardiac functional responsiveness to norepinephrine, arterial remodeling, and the effect of beta-blockade on cardiac hypertrophy.

Authors:  Lexa Rae Turner; Daniel Aaron Premo; Brett Jason Gibbs; Megan Lesley Hearthway; Madelyne Motsko; Andrea Sappington; LeeAnn Walker; Michael Eugene Mullendore; Herbert George Chew
Journal:  BMC Physiol       Date:  2002-01-09

Review 6.  Epidemiological associations between iron and cardiovascular disease and diabetes.

Authors:  Debargha Basuli; Richard G Stevens; Frank M Torti; Suzy V Torti
Journal:  Front Pharmacol       Date:  2014-05-20       Impact factor: 5.810

7.  Iron dextran increases hepatic oxidative stress and alters expression of genes related to lipid metabolism contributing to hyperlipidaemia in murine model.

Authors:  Maísa Silva; Joyce Ferreira da Costa Guerra; Ana Flávia Santos Sampaio; Wanderson Geraldo de Lima; Marcelo Eustáquio Silva; Maria Lucia Pedrosa
Journal:  Biomed Res Int       Date:  2015-01-18       Impact factor: 3.411

8.  Iron Profile and Glycaemic Control in Patients with Type 2 Diabetes Mellitus.

Authors:  Gunjan Misra; Surendra Kumar Bhatter; Ajai Kumar; Varsha Gupta; Mohd Y Khan
Journal:  Med Sci (Basel)       Date:  2016-12-09

9.  Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19.

Authors:  Joe M McCord; Brooks M Hybertson; Adela Cota-Gomez; Kara P Geraci; Bifeng Gao
Journal:  Antioxidants (Basel)       Date:  2020-06-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.